At a glance
ClinicalIndex Comparison RecordN/ACompleted· 162 enrolled
Drug / intervention
Silver Sulphadiazine Ag cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Randomized, Comparative, Multi-centre Investigation Evaluating the Efficacy and Tolerance of Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.
In Brief
A clinical study evaluating Mepilex Ag and Silver Sulphadiazine Ag cream for Burn Injuries. Completed, enrolled 162 participants across 9 sites.
Detailed Summary
The purpose is to compare time to healing using absorbent foam silver dressing (Mepilex Ag) compared to a silver sulfadiazine (SSD) 1% cream in the treatment of partial thickness burn injuries.284 in-patients in 8-12 centres in China will be evaluated. Treatment period will be up to 4 weeks with either Mepilex Ag or SSD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBurn Injuries
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedSep 2011
Primary CompletionSep 2013
TodayJul 2026
First PostedSep 22, 2011
Enrollment StartSep 1, 2011
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 14.8 years ago
Interventions
Mepilex Agdevice
Dressing
Silver Sulphadiazine Ag creamdrug
A cream used on burnt areas.